|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current Assets | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Accounts receivable, net | |||||||||||||
| Inventories | |||||||||||||
| Restricted assets-current | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Long-term investments | |||||||||||||
| Property and equipment, net | |||||||||||||
| Deferred income tax assets, net | |||||||||||||
| Operating lease assets | |||||||||||||
| Other assets | |||||||||||||
| Total assets | |||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||||
| Current Liabilities | |||||||||||||
| Notes and accounts payable | |||||||||||||
| Income tax payable | |||||||||||||
| Refund liabilities | |||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||
| Total current liabilities | |||||||||||||
| Other long-term liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Shareholders' Equity | |||||||||||||
| Ordinary Shares at US$0.01 par value per share Authorized: 500,000 thousand shares Issued and outstanding: 134,764 thousand shares in 2024 and 134,245 thousand shares in 2025 | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated other comprehensive income | |||||||||||||
| Retained earnings | |||||||||||||
| Total shareholders' equity | |||||||||||||
| Total liabilities and shareholders' equity | |||||||||||||
Loading...
